Cargando…
Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803349/ https://www.ncbi.nlm.nih.gov/pubmed/35114114 http://dx.doi.org/10.1016/S1470-2045(21)00708-7 |
| _version_ | 1784642851829710848 |
|---|---|
| author | Pfeiler, Georg DeMichele, Angela Dueck, Amylou C Fesl, Christian Gnant, Michael Mayer, Erica L |
| author_facet | Pfeiler, Georg DeMichele, Angela Dueck, Amylou C Fesl, Christian Gnant, Michael Mayer, Erica L |
| author_sort | Pfeiler, Georg |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8803349 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88033492022-02-01 Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic Pfeiler, Georg DeMichele, Angela Dueck, Amylou C Fesl, Christian Gnant, Michael Mayer, Erica L Lancet Oncol Comment Elsevier Ltd. 2022-02 2022-01-31 /pmc/articles/PMC8803349/ /pubmed/35114114 http://dx.doi.org/10.1016/S1470-2045(21)00708-7 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Pfeiler, Georg DeMichele, Angela Dueck, Amylou C Fesl, Christian Gnant, Michael Mayer, Erica L Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic |
| title | Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic |
| title_full | Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic |
| title_fullStr | Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic |
| title_full_unstemmed | Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic |
| title_short | Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic |
| title_sort | safety of adjuvant cdk4/6 inhibitors during the covid-19 pandemic |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803349/ https://www.ncbi.nlm.nih.gov/pubmed/35114114 http://dx.doi.org/10.1016/S1470-2045(21)00708-7 |
| work_keys_str_mv | AT pfeilergeorg safetyofadjuvantcdk46inhibitorsduringthecovid19pandemic AT demicheleangela safetyofadjuvantcdk46inhibitorsduringthecovid19pandemic AT dueckamylouc safetyofadjuvantcdk46inhibitorsduringthecovid19pandemic AT feslchristian safetyofadjuvantcdk46inhibitorsduringthecovid19pandemic AT gnantmichael safetyofadjuvantcdk46inhibitorsduringthecovid19pandemic AT mayererical safetyofadjuvantcdk46inhibitorsduringthecovid19pandemic |